List of Tables
Table 1. Global Primary Hyperoxaluria Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Primary Hyperoxaluria Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Primary Hyperoxaluria Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Primary Hyperoxaluria Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Primary Hyperoxaluria Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Primary Hyperoxaluria Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Primary Hyperoxaluria Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Primary Hyperoxaluria Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Primary Hyperoxaluria Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Primary Hyperoxaluria Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Primary Hyperoxaluria Drug, Product Type & Application
Table 12. Global Key Manufacturers of Primary Hyperoxaluria Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Primary Hyperoxaluria Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Hyperoxaluria Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Primary Hyperoxaluria Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Primary Hyperoxaluria Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Primary Hyperoxaluria Drug Sales Market Share by Region (2020-2025)
Table 19. Global Primary Hyperoxaluria Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Primary Hyperoxaluria Drug Sales Market Share by Region (2026-2031)
Table 21. Global Primary Hyperoxaluria Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Primary Hyperoxaluria Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Primary Hyperoxaluria Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Primary Hyperoxaluria Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Primary Hyperoxaluria Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Primary Hyperoxaluria Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Primary Hyperoxaluria Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Primary Hyperoxaluria Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Primary Hyperoxaluria Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Primary Hyperoxaluria Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Primary Hyperoxaluria Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Primary Hyperoxaluria Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Primary Hyperoxaluria Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Primary Hyperoxaluria Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Primary Hyperoxaluria Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Primary Hyperoxaluria Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Primary Hyperoxaluria Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Primary Hyperoxaluria Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Primary Hyperoxaluria Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Primary Hyperoxaluria Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Primary Hyperoxaluria Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Primary Hyperoxaluria Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Primary Hyperoxaluria Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Primary Hyperoxaluria Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Primary Hyperoxaluria Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Primary Hyperoxaluria Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Primary Hyperoxaluria Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Primary Hyperoxaluria Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Primary Hyperoxaluria Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Primary Hyperoxaluria Drug Sales Market Share by Type (2020-2025)
Table 53. Global Primary Hyperoxaluria Drug Sales Market Share by Type (2026-2031)
Table 54. Global Primary Hyperoxaluria Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Primary Hyperoxaluria Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Primary Hyperoxaluria Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Primary Hyperoxaluria Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Primary Hyperoxaluria Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Primary Hyperoxaluria Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Primary Hyperoxaluria Drug Sales Market Share by Application (2020-2025)
Table 63. Global Primary Hyperoxaluria Drug Sales Market Share by Application (2026-2031)
Table 64. Global Primary Hyperoxaluria Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Primary Hyperoxaluria Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Primary Hyperoxaluria Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Primary Hyperoxaluria Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Primary Hyperoxaluria Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Primary Hyperoxaluria Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. Allena Pharmaceuticals Inc Company Information
Table 71. Allena Pharmaceuticals Inc Description and Business Overview
Table 72. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product
Table 74. Allena Pharmaceuticals Inc Recent Developments/Updates
Table 75. Alnylam Pharmaceuticals Inc Company Information
Table 76. Alnylam Pharmaceuticals Inc Description and Business Overview
Table 77. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product
Table 79. Alnylam Pharmaceuticals Inc Recent Developments/Updates
Table 80. Dicerna Pharmaceuticals Inc Company Information
Table 81. Dicerna Pharmaceuticals Inc Description and Business Overview
Table 82. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product
Table 84. Dicerna Pharmaceuticals Inc Recent Developments/Updates
Table 85. Intellia Therapeutics Inc Company Information
Table 86. Intellia Therapeutics Inc Description and Business Overview
Table 87. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product
Table 89. Intellia Therapeutics Inc Recent Developments/Updates
Table 90. OxThera AB Company Information
Table 91. OxThera AB Description and Business Overview
Table 92. OxThera AB Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. OxThera AB Primary Hyperoxaluria Drug Product
Table 94. OxThera AB Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Primary Hyperoxaluria Drug Distributors List
Table 98. Primary Hyperoxaluria Drug Customers List
Table 99. Primary Hyperoxaluria Drug Market Trends
Table 100. Primary Hyperoxaluria Drug Market Drivers
Table 101. Primary Hyperoxaluria Drug Market Challenges
Table 102. Primary Hyperoxaluria Drug Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Primary Hyperoxaluria Drug
Figure 2. Global Primary Hyperoxaluria Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Primary Hyperoxaluria Drug Market Share by Type: 2024 & 2031
Figure 4. ALLN-230 Product Picture
Figure 5. DCR-PHXC Product Picture
Figure 6. ALN-GO1 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Primary Hyperoxaluria Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Primary Hyperoxaluria Drug Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Primary Hyperoxaluria Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Primary Hyperoxaluria Drug Market Size (2020-2031) & (US$ Million)
Figure 15. Global Primary Hyperoxaluria Drug Sales (2020-2031) & (K Pcs)
Figure 16. Global Primary Hyperoxaluria Drug Average Price (USD/Pcs) & (2020-2031)
Figure 17. Primary Hyperoxaluria Drug Report Years Considered
Figure 18. Primary Hyperoxaluria Drug Sales Share by Manufacturers in 2024
Figure 19. Global Primary Hyperoxaluria Drug Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Primary Hyperoxaluria Drug Players: Market Share by Revenue in Primary Hyperoxaluria Drug in 2024
Figure 21. Primary Hyperoxaluria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Primary Hyperoxaluria Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Primary Hyperoxaluria Drug Sales Market Share by Country (2020-2031)
Figure 24. North America Primary Hyperoxaluria Drug Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Primary Hyperoxaluria Drug Sales Market Share by Country (2020-2031)
Figure 28. Europe Primary Hyperoxaluria Drug Revenue Market Share by Country (2020-2031)
Figure 29. Germany Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Primary Hyperoxaluria Drug Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Primary Hyperoxaluria Drug Revenue Market Share by Region (2020-2031)
Figure 36. China Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Primary Hyperoxaluria Drug Sales Market Share by Country (2020-2031)
Figure 47. Latin America Primary Hyperoxaluria Drug Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Primary Hyperoxaluria Drug Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. U.A.E Primary Hyperoxaluria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Primary Hyperoxaluria Drug by Type (2020-2031)
Figure 57. Global Revenue Market Share of Primary Hyperoxaluria Drug by Type (2020-2031)
Figure 58. Global Primary Hyperoxaluria Drug Price (USD/Pcs) by Type (2020-2031)
Figure 59. Global Sales Market Share of Primary Hyperoxaluria Drug by Application (2020-2031)
Figure 60. Global Revenue Market Share of Primary Hyperoxaluria Drug by Application (2020-2031)
Figure 61. Global Primary Hyperoxaluria Drug Price (USD/Pcs) by Application (2020-2031)
Figure 62. Primary Hyperoxaluria Drug Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
